COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic

Accumulating evidence has clearly suggested that cardiometabolic risk factors such as obesity, hypertension, dyslipidemia and diabetes mellitus (DM) are associated with a more severe disease course and worse clinical outcomes of coronavirus disease 2019 (COVID-19) [1].

Source: Metabolism - Clinical and Experimental - March 25, 2021 Category: Biomedical Science Authors: Christopher M. Tessier, Alexander Kokkinos, Geltrude Mingrone, Chrysi Koliaki, Juleen R. Zierath, Christos S. Mantzoros Tags: COVID-19 in Metabolism Source Type: research